![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 41, 26408-26414, October 9, 1998
§,
, and
From the
Department of Biological Sciences, Institute
of Environmental and Natural Sciences, Lancaster University, Bailrigg,
Lancaster, LA1 4YQ United Kingdom, the ¶ Polymer Centre, School of
Physics and Chemistry, Lancaster University, Bailrigg, Lancaster, LA1
4YA United Kingdom, and the
Royal Veterinary College (University
of London), Department of Veterinary Basic Science, Royal College
Street, London, NW1 0TU United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
Alkaline borohydride-reduced keratan sulfate
chains were isolated from human articular cartilage aggrecan from
individuals of various ages (0-85 years old). The chains were
structurally characterized using 1H NMR spectroscopy,
gel permeation chromatography, and oligosaccharide profiling (after
digestion with the enzymes keratanase and keratanase II). The results
show that from birth to early adolescence (0-9 years) the levels of
(1-3)-fucosylation,
(2-3)-sialylation, and galactose sulfation
increase. Also, the weight-average molecular weight of the chains
increases. During maturation (9-18 years) the levels of fucosylation
and galactose sulfation continue to increase and
(2-6)-sialylation
of the chains occurs. In adult life (18-85 years) there is little
change in the weight-average molecular weight of the chains, and the
levels of fucosylation, sialylation, and sulfation remain fairly
constant.
| |
INTRODUCTION |
|---|
|
|
|---|
Cartilage consists of a sparse array of cells (chondrocytes) distributed within an extracellular matrix of macromolecules that they secrete. Polyanionic proteoglycans are trapped within a network of collagen fibers, and these serve to attract and organize water molecules to form a viscoelastic gel that provides tissue resilience and compressibility. The major proteoglycan within cartilage is the large aggregating proteoglycan, aggrecan. This consists of a central protein core (250-300 kDa) that is substituted with the glycosaminoglycans, keratan sulfate, and chondroitin sulfate. Up to 50 KS1 chains can be present, most of which are clustered together in a KS-rich domain close to the N terminus of the protein core (1, 2).
The concentration of keratan sulfate in human cartilage increases markedly during maturation, but it continues to increase throughout life (3-6). This increase is mostly due to the decrease in aggrecan size that occurs during aging (7-9), which results in a proteoglycan containing proportionally more keratan sulfate. This may be partly due to the KS chains themselves increasing in size (10, 11), although some studies have reported finding no change in chain size with age (12). Other research has suggested that the level of sulfation of KS increases during normal aging, although these investigations were not extensive and did not provide any details of the structural changes occurring in the glycosaminoglycan (13-15).
It is now apparent that catabolic products of aggrecan can be detected in serum in the process of cartilage breakdown, and these may be important for the early diagnosis of degenerative joint disease. Several groups have demonstrated that osteoarthritic patients have significantly higher levels of KS in both serum (16-19) and synovial fluid of the affected joint (18, 20, 21). However, other studies have recorded no change in the circulating and synovial fluid concentrations of KS in osteoarthritic patients (22, 23). The analysis of KS in body fluids has almost invariably been measured using enzyme-linked immunosorbent assay with monoclonal antibodies recognizing specific sulfation epitopes. These are likely to be structural features of only a small proportion of the glycosaminoglycan chains, and this, together with the natural heterogeneous expression of osteoarthritis, is probably the main reason for the apparently conflicting published data.
The structure of keratan sulfate is based upon a
poly-N-acetyllactosamine backbone of
Gal
(1-4)GlcNAc
(1-3) which is almost always sulfated on C(6) of
N-acetylglucosamine but to a variable extent on C(6) of
galactose (24). KS derived from articular cartilage contains sialic
acid (N-acetylneuraminic acid) and fucose as minor
structural components. The sialic acid residues can be either
(2-3)- or
(2-6)-linked to galactose and occupy nonreducing terminal positions. Both types are present at the end of the
poly-N-acetyllactosamine repeat sequence (25), and
(2-3)-NeuAc is found in the linkage region (to protein). The fucose
residues are linked
(1-3) to N-acetylglucosamine and
occur within the main poly-N-acetyllactosamine repeat (26,
27). Thus, there are numerous structural aspects of the molecule that
could give rise to unique "markers" of normal aging and also
specifically reflect abnormal metabolic responses in diseased tissue.
In the present study, keratan sulfates have been isolated from aggrecan
derived from human articular cartilage of different ages, and their
detailed structure has been investigated using 1H NMR
spectroscopy and degradative studies.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Materials-- Guanidine hydrochloride (practical grade), benzamidine hydrochloride, N-ethylmaleimide, and sodium borohydride were obtained from Sigma. Caesium chloride, di-sodium EDTA, and 6-amino-hexanoic acid were purchased from BDH Chemicals (Poole, UK). Lithium perchlorate (A.C.S. grade), piperazine, anhydrous hydrazine, and hydrazine sulfate were from Aldrich. All other chemicals were of analytical grade.
Diphenyl carbamyl chloride-treated trypsin (bovine pancreas, EC 3.4.21.4) was purchased from Sigma. Chondroitin ABC lyase (Proteus vulgaris, EC 4.2.2.4) and keratanase II (Bacillus sp.) were obtained from ICN Biomedicals Ltd. (High Wycombe, Buckinghamshire, UK). Sepharose CL-6B and Sephadex G-50 (medium grade) were obtained from Pharmacia Fine Chemicals (Uppsala, Sweden). Bio-Gel P2 (fine grade) was from Bio-Rad. The Mono-Q HR
(5 × 0.5 mm) column was
obtained from Pharmacia. The Bio-Gel TSK 30 XL (30 × 0.78 cm) and
Aminex HPX-87H columns were from Bio-Rad. Visking dialysis tubing and
Spectrapor 1 membrane (Mr cutoff 6000-8000) was
purchased from Medicell International (London, UK).
Preparation of Human Articular Cartilage Keratan Sulfates-- Keratan sulfate chains were prepared essentially by the method described by Dickenson et al. (28). This involved the extraction of the proteoglycans from comminuted cartilage (from the femoral head, femoral condyle, or patella; see Table I) using 4 M guanidine hydrochloride including protease inhibitors followed by associative CsCl density gradient centrifugation. Typically over 95% of the extractable KS was present in the high buoyant density fraction. The proteoglycan aggregate fraction was digested with chondroitin ABC lyase followed by diphenyl carbamyl chloride-treated trypsin and then subjected to gel permeation chromatography on a column of Sepharose CL-6B (114 × 2.6 cm) eluted with 0.5 M sodium acetate/10 mM EDTA. Fractions were pooled to give the peptido-glycan fragments 6B1 (i.e. the KS-rich region, typical yield >85% of total KS present). KS chains were subsequently isolated by alkaline borohydride reduction (29) followed by chondroitin ABC lyase digestion and gel permeation chromatography on a column of Sephadex G-50 (82 × 1.5 cm) eluted with 0.15 M NaCl (typical yield, >90% total KS present). After dialysis against water, the KS chains were recovered by lyophilization and then purified further from any remaining O-linked oligosaccharides (30) by ion exchange chromatography on a Pharmacia Mono-Q HR 5/5 column (5 × 0.5 cm) eluted with a linear gradient of 0-0.5 M LiClO4/10 mM piperazine (typical yield, >95% total KS present). Whenever possible column fractions were pooled identically for each sample to ensure comparability.
Keratan Sulfate Hydrodynamic Size--
Estimations of keratan
sulfate hydrodynamic size were made using a Bio-Gel TSK 30 XL column
(30 × 0.78 cm) as described earlier (31). Weight-average
molecular weights (Mw) of keratan sulfates were
calculated using the following formula: logMw = 4.588
(2.128 × Kav).
Vo and Vt are 11.4 and
20.0 min, respectively.
Carbohydrate Analysis-- Fucose and galactose contents and ratios were determined by carbohydrate analysis as described by Tai et al. (26) using conditions similar to those described by Lohmander (32) with post-column derivatization using 2-cyanoacetamide (33).
Keratanase Digestion-- Keratan sulfate chains (200 µg) were dissolved in 200 µl of 0.2 M sodium acetate, pH 7.4, and 0.07 units of enzyme were added (equivalent to 1 unit/2.8 mg KS). Digestion was performed at 37 °C for 24 h. These conditions had previously been determined to give a limit digest. The digest was reduced by the addition of 200 µl of 2 M NaBH4/0.1 M NaOH at 45 °C for 24 h. The reaction was terminated by the careful addition of 0.5 M CH3COOH, and the oligosaccharides were desalted on a column of Bio-Gel P2 and lyophilized. The reduced oligosaccharides were subjected to gel filtration on a TSK 30 XL column as described previously.
Keratanase II Digestion-- Keratan sulfate chains (100 µg) were dissolved in sodium acetate buffer (100 µl), and 200 microunits enzyme were added. Digestion was performed at 37 °C for 30 h. These conditions had previously been determined to give a limit digest. The pH of the mixture was raised to approximately 7.5 using 2 M NH4OH, and 3.8 mg of NaBH4 were added (equivalent to 1 M). Reduction was performed at room temperature for 3 h. The reaction was terminated by the careful addition of 0.5 M CH3COOH, and the oligosaccharides were desalted on a column of Bio-Gel P2 and lyophilized. Approximately 10 µg of the reduced oligosaccharides were chromatographed on a Dionex AS4A-SC column using the procedure of Brown et al. (34).
NMR Spectroscopy-- Samples were prepared for high field NMR spectroscopy as described previously (38). Spectra were determined at either 23 or 55 °C, the chemical shift of the residual HO2H signal varying with temperature. All chemical shifts are quoted relative to internal sodium 3-(trimethylsialyl)-[2H4]propionate at 0.0 ppm. Spectra were reprocessed for presentation using the NMRi software package, NMR1, version 1-3-4, supplied by New Methods Research Inc. (Syracuse, NY). Axes for spectra are in ppm.
| |
RESULTS |
|---|
|
|
|---|
KS Chain Hydrodynamic Size
The hydrodynamic sizes of the human articular cartilage keratan sulfate chains were determined on a TSK 30 XL column previously calibrated using keratan sulfate oligosaccharides (Table I). The results shown in Fig. 1 demonstrate that the KS chains isolated from the two full term fetal (Mw = 4000 and 4700) and 5-year-old (Mw = 4850 and 5850) cartilage samples are significantly smaller in size than those from the older specimens over the age of 9 years old (Mw average = 6750 ± 700). A significant increase in average chain size occurs during adolescence (0-9 years), and although KS preparations from individual adult specimens display a high degree of variability (Mw range, 5700-8250), the data suggest that over 9 years of age there is little change in KS molecular weight.
|
|
NMR Spectroscopic Studies
Sulfation Levels-- Several signals in the 1H NMR spectra of keratan sulfates yield information on the level and position (Gal or GlcNAc) of sulfation. The GlcNAc H(1) anomeric resonances occur at ~4.75 ppm and are known to be sensitive to their immediate sulfation environment (36). When the galactose residue on the reducing side of the GlcNAc is sulfated the H(1) resonance occurs at ~4.76 ppm; however, when the galactose is unsulfated the signal occurs at ~4.74 ppm These shift differences usually give rise to a signal resembling a triplet consisting of two overlapping doublets. In addition, as galactose sulfation increases, a signal at ~3.97 ppm deriving from the H(5) of a sulfated galactose increases in intensity (37). However, quantitative interpretations based upon the size of this resonance are difficult due to the presence of other underlying resonances. It should be noted that in all preparations of articular cartilage keratan sulfates we have investigated, both human and bovine, no unsulfated N-acetylglucosamine residues have been detected.
All of the human KS samples have been analyzed by 1H NMR spectroscopy. Representative partial high field spectra of keratan sulfates isolated from full term fetal and 11-, 31-, and 38-year-old human articular cartilage are shown in Fig. 2. It can be seen that the pattern of signals at ~4.75 ppm varies between samples reflecting differences in galactose sulfation levels. The fetal samples possess the lowest galactose sulfation level (~20-30%), whereas the 31- and 38-year-old samples are much more highly sulfated (~70-80%). The 11-year-old sample is intermediate at 50-60%. In general, the samples up to 11 years of age exhibit galactose sulfation levels of 20-50%, whereas those of samples within the 18-85-year-old range are between 60 and 80%. This suggests that galactose sulfation levels increase during adolescence and early maturation and then remain fairly constant. However, it is also possible that KS chains with increased galactose sulfation levels have a longer half-life than their less sulfated counterparts and that this apparent increase in sulfation of the KS population as a whole reflects the faster turnover of fetal-type chains.
|
Fucosylation--
The H(1) and H(6) protons of
(1-3)-linked
fucose occur as doublet resonances at ~5.12 and ~1.17 ppm,
respectively (37). These signals occur within regions of the
1H NMR spectrum free of other KS signals and so tend to be
clearly visible if present. Examination of the 1H NMR
spectra of the human keratan sulfates reveals the presence of
(1-3)-linked fucose in all of the samples; however, the degree of
substitution varies considerably. It is evident that the fetal KS
samples contain the lowest amount of this component (0.1% w/w, determined by carbohydrate analysis) with a H(1) doublet resonance only
just visible in the 1H spectrum at ~5.12 ppm (Fig.
2a). Similarly, all the KS samples up to 11 years old (Fig.
2b) also contain markedly lower levels of fucose (0.1-0.4%
w/w) than the other human samples studied from the older ages (18-85
years old), which generally contain fucose at the ~1.5% level (Fig.
2c). The most notable exception is that isolated from a
38-year-old (sample (i)), which contains a much higher level at 2.7%
(Fig. 2d). Clearly, the fucose content of human articular
cartilage keratan sulfates increases during adolescence. During
subsequent aging, KS chains from most adult individuals have similar
fucose contents; however, there are exceptions, and some samples show a
markedly different composition, the cause of which is unknown.
Sialylation--
The H(3ax) and H(3eq)
protons of
(2-3)-linked sialic acid give rise to characteristic
resonances at ~1.80 and 2.77 ppm, respectively, whereas those
slightly further upfield at ~1.70 and 2.70 ppm derive from sialic
acid that is
(2-6)-linked. Although quantitative interpretations of
these signals are difficult due to the complexity of the overlapping
resonances, careful analysis of high field spectra can identify the
presence (or absence) of sialic acid in a discrete environment. Table
II gives details of the sialic acid
H(3ax) and H(3eq) proton chemical shifts in the
several sialic acid-containing environments identified for bovine
articular cartilage keratan sulfates occurring as either capping
sequence or linkage region oligosaccharides (38).
|
(2-6)-linked sialic acid
and that the level of
(2-3)-linked sialic acid is much lower than
in the other human samples studied (Fig. 3a). This finding
is surprising because these samples might have been expected to contain
proportionally more sialic acid than those from the older ages because
the hydrodynamic size of the chains appears to be much smaller
(Mw = 4000 and 4700). Analysis of the
(2-3)-linked
sialic acid signals at ~1.8 ppm indicates the presence of at least
two environments. The major component at 1.805 ppm corresponds to
sialic acid in the capping sequence
NeuAc
(2-3)Gal
1-4GlcNAc(6S)
1-, whereas the minor component (at 1.794 ppm) represents the
(2-3)-linked sialic acid in the linkage region. The highly sulfated cap,
NeuAc
(2-3)Gal(6S)
1-4GlcNAc(6S)
1-, is not detectable in the
1H NMR spectrum of fetal KS, presumably due to the low
level of sulfation within these samples. The 5-year-old samples also
contain no detectable
(2-6)-linked sialic acid; however, the
(2-3)-linked sialic acid content is broadly equivalent with that
found in most of the older samples (Fig. 3b). The 9- and
11-year-old samples also contain little if any
(2-6)-linked sialic
acid, although levels of
(2-3)-linked sialic acid are normal. The
remainder of the human samples all demonstrate the presence of five
sialic acid environments summarized in Table II, with the sequence
NeuAc
(2-3)Gal(6S)
1-4GlcNAc(6S)
1- as the dominant structure
(Fig. 3, c and d), although the relative proportions vary considerably, particularly the
(2-6)-linked sialic
acid content.
|
Degradative Studies
Keratanase Digestion--
Four human keratan sulfate samples
(namely 19(i)-, 24-, 38(i)-, and 85-year-old) containing similar
galactose sulfation levels as judged by NMR spectroscopy were digested
with keratanase (an endo-
-galactosidase) to assess the size of the
fully sulfated block structures. Examination of the gel permeation
chromatograms shown in Fig. 4 indicates
considerable variation in the pattern of enzyme digestion. It can be
seen that the sample from the 19-year-old is relatively resistant to
degradation by the enzyme, resulting in a relatively high proportion of
large oligosaccharides. This has two potential implications for the
detailed microstructure of the chains. Either the sample possesses a
large proportion of fully sulfated blocks, possibly separated by
keratanase-sensitive oligosaccharide sequences possessing low galactose
sulfation, or it contains a high proportion of fucose residues that are
known to inhibit the action of the enzyme (39). Providing that the fucose is evenly distributed within the repeat sequence, the latter hypothesis can be discounted because this sample contained a fucose content (1.4%) similar to that in the 24- and 85-year-old samples (1.3 and 1.5%, respectively), which were fragmented to a much greater
extent (Fig. 4, b and d). By contrast, the sample
from the 38-year-old (Fig. 4c) produced a larger quantity of
smaller oligosaccharides, suggesting that galactose sulfation is more evenly distributed within the keratan sulfate chains.
|
Keratanase II Digestion--
The detailed structures of all the
human samples were analyzed using the keratanase II/Dionex anion
exchange chromatography oligosaccharide profiling technique described
by Brown et al. (34). It can be seen from the comparison of
partial chromatograms shown in Fig. 5
that these analyses confirm those obtained by NMR spectroscopy
regarding the age-related increases in the proportions of
(2-3)-
and
(2-6)-linked sialic acid and
(1-3)-fucose. Interestingly, oligosaccharide profiling of one of the fetal samples (Fig.
6) reveals that almost all of the fucose
and sialic acid is present in the capping structure
NeuAc
(2-3)Gal
(1-4)GlcNAc(6S)
(1-3)Gal
(1-4)[Fuc
(1-3)]GlcNAc(6S)-ol (i.e. a sulfated VIM-2 epitope; (40)). This is surprising
because the fucose content is low in this sample, and this structure is only present at very low levels in all the other KS samples studied from the older cartilages. The significance of this finding is not yet
understood; however, it is possible that such antigens may be important
in the early stages of tissue development (41).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
This is the first detailed study documenting the changes that
occur in the structure of aggrecan-derived keratan sulfate as a
function of age. It is clear that the fetal KS samples are
significantly different from those isolated from older cartilages. The
analytical data show that (i) the sulfation level on galactose is low
(~20-30%); (ii) the fucose content is very low (0.1% w/w); (iii)
(2-3)-sialylation is low; and (iv)
(2-6)-sialylation is absent.
In addition, the 1H NMR spectrum of one of the fetal KS
samples displays a doublet resonance at ~4.98 ppm (Fig.
5a) that is not present in any other human sample studied.
Although the origin of this signal is unknown, it clearly derives from
the anomeric proton of an
-linked sugar (the coupling constant is
small, ~3 Hz). This resonance has been seen before on the
1H NMR spectra of keratan sulfates isolated in this
laboratory from very young bovine articular cartilage (36) but has not yet been identified. It is possible that this fetal-specific feature represents an alternative to sialic acid as a chain cap (quite possible
considering the relative deficiency of sialic acid caps in this
sample), and the Dionex fingerprint of this sample did reveal the
presence of several minor unknown peaks (data not shown).
The KS samples from all of the younger cartilages studied (5-11 years
old) also display significant differences from those derived from older
material. The
(2-6)-linked sialic acid is either not present or
present at very low levels, and the fucose content is very low
(0.1-0.4% w/w). The sulfation level on galactose (~30-50%) is
generally intermediate between that in the fetal samples and that in
the older samples.
From the results presented here, the aging process has several implications for the detailed structure of human articular cartilage keratan sulfates (Scheme 1) and can be divided into three stages: birth to early adolescence (0-9 years), maturation (9-18 years), and adulthood (18-85 years) (Table III).
|
|
The functions of sialic acid and fucose in keratan sulfates are still
not clear. It is possible that sialic acid residues, present as chain
caps, have significance for chain degradation. Sialic acid masks the
galactose residue to which it is attached, preventing the removal of
the glycoprotein from the circulation via Gal-specific
receptors on the cell surface of hepatocytes (42). Removal of the
sialic acids by sialidases causes the rapid removal of the glycoprotein
from the circulation. It is possible that the sialic acid chain caps in
KS, present in several discrete environments, dictate the lifetime of
these molecules. At present, nothing is known about the rates of
removal of
(2-3)- versus
(2-6)-linked sialic acid
glycoproteins and glycosaminoglycans in serum. The presence of fucose
may also have potential significance for the degradation of the
molecules. Studies using the KS degrading enzymes keratanase and
keratanase II have shown that fucose residues in the vicinity of
susceptible glycosidic bonds inhibit cleavage (39).2 If glycosidases
responsible for the breakdown of KS in vivo also possess
this substrate specificity, fucosylated chains may be less susceptible
to degradation.
The interest in keratan sulfate study has been partially stimulated by
the possible assay of these molecules in the early diagnosis of
arthritic diseases and in the monitoring of cartilage catabolism. It is
known that the degradation of proteoglycans occurs early in joint
damage (43) and that fragments are released into the synovial fluid and
subsequently the serum (44, 45). The quantitation of keratan sulfates
in both serum and synovial fluid has therefore been proposed as a
measure of cartilage breakdown. Currently, most measurements involve an
enzyme-linked immunosorbent assay approach using the anti-KS
antibodies, 5D4 and MZ15, which recognize fully sulfated blocks of
hexasaccharide size and larger (46). The results obtained from
keratanase analysis of the KS chains show that even in samples where
the overall galactose sulfation levels are similar, considerable
variation in the distribution of sulfate groups can occur within the
poly-N-acetyllactosamine repeat sequence. This has
considerable significance for their study and quantitation by these
monoclonal antibodies. It is clear that for the samples studied here,
the KS chains from the 19-year-old would bind to these antibodies much
more strongly than those from the 38-year-old. It is clear that new
quantitative techniques for the assay of KS concentration need to be
developed if keratan sulfate is to be used as an accurate measure of
cartilage breakdown. The identification of oligosaccharide sequences
unique (or present in high abundance) to KSs in high load-bearing areas
may be important to this goal. The lesions leading to osteoarthritis
are known to appear first in the most highly loaded areas of the
cartilage surface (47), and it is possible that "load-related
epitopes" could be present in high concentrations in synovial fluid
(and possibly blood) of patients with arthritic disease. At Lancaster, studies are now in progress to identify such load-related epitopes and
determine whether they are present in keratan sulfates and whether
their detection and quantitation can be used to monitor cartilage
loading and hence breakdown of the extracellular matrix. The discovery
that both
(1-3)-linked fucose and
(2-6)-linked sialic acid are
present only in articular (i.e. load-bearing) cartilage
keratan sulfates (48) and that their proportions change significantly
during adolescence at a time when extensive cartilage remodelling is
occurring suggests that putative load-related epitopes may contain one
or more of these structures.
| |
ACKNOWLEDGEMENTS |
|---|
Tai Guihua, Bob Lauder, and Haydn Morris are thanked for helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by the Arthritis and Rheumatism Council and the Biotechnology and Biological Sciences Research Council.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 44-1524-593252; Fax: 44-524-843854; E-mail: g.m.brown{at}lancaster.ac.uk.
The abbreviations used are:
KS, keratan sulfate; GlcNAc, N-acetylglucosamine
(2-acetamido-
-D-glucose)Gal,
-D-galactose6S, O-ester sulfate group on
C(6)Fuc,
-L-fucoseNeuAc, sialic acid
(N-acetylneuraminic acid).
2 K. M. Whitham, unpublished results.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. J. Wayne, S.-J. Deng, A. Amour, S. Borman, R. Matico, H. L. Carter, and G. Murphy TIMP-3 Inhibition of ADAMTS-4 (Aggrecanase-1) Is Modulated by Interactions between Aggrecan and the C-terminal Domain of ADAMTS-4 J. Biol. Chem., July 20, 2007; 282(29): 20991 - 20998. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Poon, A. H. Plaas, D. R. Keene, D. J. McQuillan, K. Last, and A. J. Fosang N-Linked Keratan Sulfate in the Aggrecan Interglobular Domain Potentiates Aggrecanase Activity J. Biol. Chem., June 24, 2005; 280(25): 23615 - 23621. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.K. Plaas, L. A. West, and R. J. Midura Keratan sulfate disaccharide composition determined by FACE analysis of keratanase II and endo-{beta}-galactosidase digestion products Glycobiology, October 1, 2001; 11(10): 779 - 790. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |